News

Bavarian Nordic has initiated two Phase III clinical trials of its mpox vaccine, Jynneos, in pregnant and breastfeeding women ...
Clinical trials of Jynneos have begun or will begin soon in infants and children 2 years old and younger, and in pregnant or ...
More measles cases have been reported in Washington state. Officials in Seattle-King County yesterday reported two measles ...
Saint-Herblain, France, June 26, 2025 – Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s ...